Search Results
108 items found for "ascitic currents"
- G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression
Here, we discuss the current understanding of the roles of GPCRs and their signaling pathways in tumor
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Tobias Langenhan's group, where I currently manage a project to establish a drug screening assay for Laurent is currently leading DTNA discovery group working on GPCRs in immuno-oncology to discover new Cancer (IRIC), Université de Montréal, Montreal, Quebec, Canada " About Ana Lilia Moreno Salinas "I am currently
- Illuminating Functional Selectivity and Allosterism at GPCRs.
The Canadian Institutes for Health Research and March of Dimes currently support his research."
- Noval insights and therapeutic strategies for tumor-induced kidney pathologies
We also acknowledged the limitations of current experimental models in this study and emphasized the
- Ep 150 with Dr GPCR Team
She is also very active within the pharmacology community and currently serves on the editorial board Currently serving as a Post Doctoral research fellow at Monash University, John plays a pivotal role
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis Published date April 11, 2023 Abstract " The current
- Ep 70 with Dr. Stephen Ferguson
He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for
- Legal Policies and Disclaimers | Dr. GPCR Ecosystem
You can review the most current versions at any time on our Website.
- Targeting adenosine signaling for immuno-oncology
Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized
- Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ
methylation in the cells treated with TGFβ and Interferonγ Published date June 28, 2023 Abstract "In this current
- Chemoattractant receptor signaling in humoral immunity
In this review, we summarize the current understanding of chemoattractant receptor signaling in the context
- Chemokine Physiology in Cancer
In this article we review current literature on the diversity of chemokine ligands and their cellular
- Applying Pharmacology to Drug Discovery | Dr. GPCR Ecosystem
I then moved to the University of North Carolina School of Medicine where currently I am a Professor
- The path of GPR87: from a P2Y-like receptor to its role in cancer progression
natural ligand for this cell surface receptor, these data are preliminary and inconsistent, and IUPHAR is currently
- Biochemical pharmacology of adenylyl cyclases in cancer
In addition, we highlight inhibitors of AC-related signaling that are currently under investigation,
- Ep 69 with Dr. Stephen Ferguson
He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for
- Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
Sudarshan Rajagopal is a physician-scientist and is currently an Associate Professor of Medicine and
- Ep 144 with Dr Aurélien Rizk
Yamina Berchiche and Aurelien Rizk engaged in a conversation about their professional backgrounds and current Discussed Yamina Berchiche and Aurelien Rizk had a conversation about their professional backgrounds and current The discussion ended with Aurelien Rizk sharing his current work on numerical simulations of fluid dynamics
- Ep 154 with Dr Badr Sokrat
My current research focuses on investigating GPCR signaling and trafficking in the context of inflammation discussed the concept of serendipity in scientific research, illustrating with examples of Kathleen Curran Yamina expressed interest in understanding how Badr’s experiences influenced his current role, and Badr of starting a project independently and then delegating tasks, while Badr shared his plans for his current
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
I am currently completing my postdoctoral research in the laboratory of the late Dr.
- Unveiling Non-Canonical Functions for Gαq Signaling Pathways
Catalina Ribas, is currently an Associate Professor at the University Autonomous of Madrid (UAM) and
- Principles of Pharmacology in Drug Discovery I | Dr. GPCR Ecosystem
I then moved to the University of North Carolina School of Medicine where currently I am a Professor
- Ep 106 with Dr. Bruno Giros
and postdoc students, most of his trainees obtain positions in the academic or private sectors or are currently
- Ep 78 with Dr. Stuart Maudsley
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
Although G protein-coupled receptors (GPCRs) are among the targets of current antifibrotic drugs, no
- Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors
The pathogenesis of Long-COVID is currently under heavy scrutiny and existing data on the role of auto-immune
- Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer
Taken together, current data are prompting the hypothesis of a prophylactic treatment option with stable
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
signaling-associated genes (SphK1 and S1PRs) and their role in BCR-ABL1-independent resistant CML, an area currently